Dave Kocisko is a motivated scientist with extensive experience across pre-clinical and clinical drug development, focusing on neurodegenerative diseases. Currently serving as a Sr Medical Science Liaison at Genentech, Dave supports the thrombolytics program and has previously contributed to the development of gantenerumab for Alzheimer's disease. With a strong research background and multiple publications in top journals, Dave has held roles at Biogen Idec, Eli Lilly and Company, and Amgen, advancing treatments in Alzheimer's and other conditions. Dave earned a PhD in Chemistry from the Massachusetts Institute of Technology, specializing in peptide chemistry and protein structure.
This person is not in the org chart
This person is not in any teams
This person is not in any offices